Quintiles Phase I Services — Overland Park, Kansas

Quintiles Phase I Services is a clinical research site located in Overland Park, Kansas, United States 66211.

Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.

Quintiles Phase I Services has participated in 9 clinical trials.

Therapeutic areas: Anthrax, Healthy, Nocturia.

Sponsors: PharmAthene, Inc., Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc., Vantia Ltd.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Overland Park

Browse all research sites in Kansas · View every site in Overland Park

Sponsor Feasibility Report

Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Quintiles Phase I Services?

Quintiles Phase I Services has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Quintiles Phase I Services conducted?

Quintiles Phase I Services has 9 clinical trials on record. Their work covers Anthrax, Healthy, Nocturia.

Is Quintiles Phase I Services accredited by Crixeo Clinical Trials?

Quintiles Phase I Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Quintiles Phase I Services?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.